[{"address1": "1400 Sierra Point Parkway", "address2": "Building C Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 822 5500", "fax": "650 636 9773", "website": "https://www.annexonbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barr\u00e9 syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.", "fullTimeEmployees": 99, "companyOfficers": [{"maxAge": 1, "name": "Mr. Douglas E. Love Esq., J.D.", "age": 57, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 1010807, "exercisedValue": 0, "unexercisedValue": 446927}, {"maxAge": 1, "name": "Dr. Ted  Yednock Ph.D.", "age": 67, "title": "Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 714668, "exercisedValue": 0, "unexercisedValue": 175585}, {"maxAge": 1, "name": "Dr. Jamie  Dananberg M.D.", "age": 66, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 715233, "exercisedValue": 0, "unexercisedValue": 154858}, {"maxAge": 1, "name": "Dr. Dean R. Artis Ph.D.", "age": 63, "title": "Chief Scientific Officer & Executive VP", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 797380, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Overdorf M.B.A.", "age": 54, "title": "Executive VP & Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 580469, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Mr. Henk-Andre  Kroon M.D.", "title": "Senior Vice President of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shikhar  Agarwal M.B.A.", "title": "Senior VP & Head of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sunil  Mehta Pharm.D.", "title": "Senior VP of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lloyd  Clark M.D.", "title": "Senior Vice President of Ophthalmology Strategy & Innovation", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.96, "open": 6.98, "dayLow": 6.755, "dayHigh": 7.18, "regularMarketPreviousClose": 6.96, "regularMarketOpen": 6.98, "regularMarketDayLow": 6.755, "regularMarketDayHigh": 7.18, "payoutRatio": 0.0, "beta": 1.194, "forwardPE": -5.7031345, "volume": 2295920, "regularMarketVolume": 2295920, "averageVolume": 2896248, "averageVolume10days": 2586820, "averageDailyVolume10Day": 2586820, "bid": 6.77, "ask": 6.91, "bidSize": 10, "askSize": 27, "marketCap": 1010598848, "fiftyTwoWeekLow": 1.285, "fiftyTwoWeekHigh": 7.18, "allTimeHigh": 38.01, "allTimeLow": 1.285, "fiftyDayAverage": 4.7786, "twoHundredDayAverage": 3.011275, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 649327424, "profitMargins": 0.0, "floatShares": 111257311, "sharesOutstanding": 149055879, "sharesShort": 16284598, "sharesShortPriorMonth": 10504723, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.1093, "heldPercentInsiders": 0.0033399998, "heldPercentInstitutions": 0.79580003, "shortRatio": 5.83, "shortPercentOfFloat": 0.12810001, "impliedSharesOutstanding": 149055879, "bookValue": 1.402, "priceToBook": 4.835949, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -208880992, "trailingEps": -1.41, "forwardEps": -1.18882, "enterpriseToEbitda": -3.0, "52WeekChange": 0.79844964, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 6.78, "targetHighPrice": 27.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.33333, "targetMedianPrice": 12.5, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 188720992, "totalCashPerShare": 1.578, "ebitda": -216468000, "totalDebt": 26938000, "quickRatio": 4.33, "currentRatio": 4.425, "debtToEquity": 16.686, "returnOnAssets": -0.44954, "returnOnEquity": -0.83985, "freeCashflow": -93057504, "operatingCashflow": -176444992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 6.7908, "postMarketChange": 0.010799885, "regularMarketChange": -0.18, "regularMarketDayRange": "6.755 - 7.18", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2896248, "fiftyTwoWeekLowChange": 5.4950004, "fiftyTwoWeekLowChangePercent": 4.276265, "fiftyTwoWeekRange": "1.285 - 7.18", "fiftyTwoWeekHighChange": -0.39999962, "fiftyTwoWeekHighChangePercent": -0.055710256, "fiftyTwoWeekChangePercent": 79.84496, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "shortName": "Annexon, Inc.", "longName": "Annexon, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1595597400000, "corporateActions": [], "postMarketTime": 1769211556, "regularMarketTime": 1769202001, "exchange": "NMS", "messageBoardId": "finmb_279883519", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.5862, "regularMarketPrice": 6.78, "marketState": "CLOSED", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "postMarketChangePercent": 0.15929033, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.41, "epsForward": -1.18882, "epsCurrentYear": -1.38229, "priceEpsCurrentYear": -4.9049044, "fiftyDayAverageChange": 2.0014, "fiftyDayAverageChangePercent": 0.41882557, "twoHundredDayAverageChange": 3.7687252, "twoHundredDayAverageChangePercent": 1.251538, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Annexon", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]